NEOPHARMA TECHNOLOGIES, LTD.
Investor Relations

Mr. Marcus L'Estrange,

Executive Chairman of the Board of Directors:

Mr. Marcus L’Estrange serves as Executive Chairman, leveraging his 20+ years of experience as a qualified engineer across IT, biomedical, mining, and oil & gas industries. His notable contributions include:

• Successfully commercializing offshore exploration software on a global scale during his tenure at Engenius Software.

• Driving global growth strategy by aligning operations and IT teams for maximum efficiency and impact.

• Bringing valuable cross-industry insights to Neopharma's operations, enhancing the company's competitive edge.

​

Ms. Nina French,

CEO & Member of the Board of Directors

Neopharma Technologies boasts a highly experienced and diverse management team, bringing together expertise in employee screening, engineering, corporate leadership, and technological innovation. This seasoned leadership is instrumental in driving the company's mission to revolutionize the AI-empowered rapid diagnostics industry.
At the helm of Neopharma Technologies is CEO Nina M French, a veteran with over 30 years of experience in the employee screening industry. Her extensive expertise includes:

• Comprehensive knowledge of drug testing program design, policies, state laws, and federal regulations.

• Extensive product development experience in the diagnostics field.

• Recognized industry leadership, including a tenure as President of the Drug & Alcohol Testing Industry Association (DATIA).

• Accomplished authorship and thought leadership in drug testing, regularly contributing to industry publications and speaking at conferences.

​

Mr. Shaun Melville,

Executive Officer & Member of the Board of Directors

Shaun Melville, the Executive Director, brings over 15 years of experience as a private and public company director in both Australian and international markets. His key achievements include:

• Successfully listing and reverse-listing multiple companies on the Australian Securities Exchange (ASX)

• Leading high-stakes negotiations for key distribution and manufacturing agreements

• Overseeing critical regulatory, legal, and design processes crucial for Neopharma's growth and compliance

Mr. Neel Le Roux - Fourth Board Member (Independent)

​Biography Pending....

​​​​​​​​​

Mr. Rob Martin - Fifth Board Member (Independent)

Biography Pending...